Medicine and Dentistry
Patient
100%
Venous Thromboembolism
65%
Inpatient
52%
Therapeutic Procedure
50%
Heparin
48%
Phlebothrombosis
41%
Thrombosis
34%
Antithrombotic
31%
Pulmonary Embolism
29%
Warfarin
28%
Apixaban
26%
Deep Vein Thrombosis
23%
Disease
19%
Low Molecular Weight Heparin
18%
Bleeding
18%
Fibrinogen
16%
Major Bleeding
16%
Prophylaxis
15%
Thromboprophylaxis
15%
Surgery
13%
Drug
13%
Chemotherapeutic Agent
13%
Combination Therapy
12%
Amaurosis
12%
Diagnosis
12%
Incidence
11%
Hospital
11%
Thromboembolism
11%
Apoplexy
10%
Low Drug Dose
10%
Leg Thrombosis
10%
Hip Replacement
10%
Global Disease Burden
9%
Evaluation Study
9%
Thrombus
9%
Age
8%
Acetylsalicylic Acid
8%
Consensus
8%
Streptokinase
8%
Recurrent Disease
7%
Mortality
7%
Iodine 125
7%
Fibrinolytic Therapy
7%
Platelet
7%
Anticoagulant Therapy
7%
Death
7%
Blood
7%
Subcutaneous Injection
7%
Malignant Neoplasm
6%
Myocardial Infarction
6%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
69%
Heparin
37%
Warfarin
37%
Anticoagulant Agent
36%
Bleeding
32%
Enoxaparin
20%
Thrombosis
19%
Lung Embolism
17%
Vein Thrombosis
16%
Deep Vein Thrombosis
16%
Diseases
12%
Drug
12%
Rivaroxaban
11%
Thromboembolism
11%
Recurrent Disease
11%
Incidence
9%
Malignant Neoplasm
8%
Low Molecular Weight Heparin
8%
Acetylsalicylic Acid
8%
Placebo
8%
Fibrinogen
7%
Antivitamin K
7%
Clinical Trial
6%
Atrial Fibrillation
6%
Antithrombocytic Agent
5%
Death
5%
Prospective Study
5%
Pharmaceutical Therapy
5%
Dextran
5%
Nursing and Health Professions
Patient
33%
Warfarin
27%
Venous Thromboembolism
24%
Heparin
21%
Thrombosis
16%
Vein Thrombosis
14%
Bleeding
12%
Practice Guideline
11%
Dose
9%
Combination Therapy
9%
Consensus
8%
International Normalized Ratio
8%
Anticoagulation
8%
Incidence
7%
Global Disease Burden
7%
Prophylaxis
7%
Anticoagulant Agent
7%
Heart Valve Prosthesis
6%
Activated Partial Thromboplastin Time
6%
Recurrent Disease
6%
Hospital
6%
Prevention
6%
Atrial Fibrillation
5%
Thromboembolism
5%
Mortality
5%
Lung Embolism
5%
Heparin Induced Thrombocytopenia
5%